Mucopolysaccharidosis Vi
📧 Sign up to get email alerts when something new happens for Mucopolysaccharidosis Vi.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI [Phase 2]
Phase 2 study evaluating the effect of losartan on cardiovascular outcomes in patients with Mucopolysaccharidosis IV A and VI.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: A Study in MPS VI to Assess Safety and Efficacy of Odiparcil [Phase 2]
Phase 2 trial assessing safety and efficacy of Odiparcil in Mucopolysaccharidosis VI has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Stem Cell Transplantation for Hurler [Phase 2]
A Phase 2 clinical trial evaluating stem cell transplantation for Hurler syndrome has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Study of rhASB in Patients With Mucopolysaccharidosis VI [Phase 3]
Phase 3 clinical trial of recombinant human arylsulfatase B (rhASB) in patients with mucopolysaccharidosis type VI completed, with results p…
-
CLINICAL_TRIALS trial_result · 2006-11-03Clinical Trial Update: Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI [Phase 1]
A Phase 1 clinical trial evaluating recombinant human N-acetylgalactosamine 4-sulfatase in patients with Mucopolysaccharidosis VI has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.